Checkmate Pharmaceuticals(CMPI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CMPI Checkmate Pharmaceuticals

停牌 12-23 18:28:35 EST

10.50

+0.00

0.00%

最高10.50	最低10.50	成交量0.00
今开10.50	昨收10.50	日振幅0.00%
总市值2.31亿	流通市值6,847万	总股本2,204万
成交额66.80万	换手率0.00%	流通股本652.09万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CMPI","market":"US","secType":"STK","nameCN":"Checkmate Pharmaceuticals","latestPrice":10.5,"timestamp":1653681600000,"preClose":10.5,"halted":3,"volume":0,"delay":0,"floatShares":6520908,"shares":22038218,"eps":-2.919537,"marketStatus":"停牌","marketStatusCode":4,"change":0,"latestTime":"12-23 18:28:35 EST","open":10.5,"high":10.5,"low":10.5,"amount":668001.841458,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.919537,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735002000000},"adr":0,"listingDate":1596772800000,"adjPreClose":10.5,"volumeRatio":0},"requestUrl":"/m/hq/s/CMPI","defaultTab":"news","newsList":[{"id":"2228202994","title":"Checkmate Pharmaceuticals Inc股价拉升331.33% 市值涨7.45亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2228202994","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2228202994?lang=zh_cn&edition=full","pubTime":"2022-04-19 21:31","pubTimestamp":1650375083,"startTime":"0","endTime":"0","summary":"北京时间2022年04月19日21时31分，Checkmate Pharmaceuticals Inc股票出现波动，股价快速上涨331.33%。Checkmate Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，Checkmate Pharmaceuticals Inc、Axsome Therapeutics Inc、Processa Pharmaceuticals Inc涨幅较大，Pharmacyte Biotech Inc、Navidea Biopharmaceuticals Inc、Diffusion Pharmaceuticals Inc较为活跃，换手率分别为25.70%、13.53%、8.08%，振幅较大的相关个股有Diffusion Pharmaceuticals Inc、Moonlake Immunotherapeutics、Celularity Inc C/Wts 24/05/2026 ，振幅分别为16.60%、13.02%、10.49%。Checkmate Pharmaceuticals Inc公司简介：Checkmate Pharmaceuticals Inc是一家临床阶段的生物技术公司，致力于开发和商业化其专有技术，以利用免疫系统的力量对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022041921312479b21871&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022041921312479b21871&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPI"],"gpt_icon":0},{"id":"2228935999","title":"美股异动 | Checkmate(CMPI.US)盘前暴涨328% 获再生元制药(REGN.US)溢价收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2228935999","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2228935999?lang=zh_cn&edition=full","pubTime":"2022-04-19 20:05","pubTimestamp":1650369906,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，再生元制药公司已同意以每股10.50美元的价格全现金收购临床阶段生物技术公司Checkmate Pharmaceuticals。截至发稿，Checkmate盘前暴涨328.22%，报10.32美元，再生元制药跌0.03%，报723.00美元。收购价使Checkmate的总股本价值接近 2.5亿美元。该交易预计将于 2022 年年中完成。据悉，Checkmate的核心产品Vidutolimod是一种差异化的TLR9激动剂。目前公司正在进行Vidutolimod针对黑色素瘤、非黑色素瘤皮肤癌和头颈癌的联合治疗的研究。此次收购将把Vidutolimod纳入再生元制药公司的免疫肿瘤产品组合中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/704998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CMPI","BK4139","BK1191","01477","BK1574","REGN"],"gpt_icon":0},{"id":"2228950563","title":"Checkmate Pharmaceuticals Inc盘中异动 临近收盘股价大跌5.12%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2228950563","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2228950563?lang=zh_cn&edition=full","pubTime":"2022-04-19 04:15","pubTimestamp":1650312915,"startTime":"0","endTime":"0","summary":"北京时间2022年04月19日04时15分，Checkmate Pharmaceuticals Inc股票出现波动，股价快速下挫5.12%。截至发稿，该股报2.41美元/股，成交量1.0163万股，换手率0.05%，振幅5.91%。Checkmate Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为2.54%。Checkmate Pharmaceuticals Inc公司简介：Checkmate Pharmaceuticals Inc是一家临床阶段的生物技术公司，致力于开发和商业化其专有技术，以利用免疫系统的力量对抗癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022041904151678015179&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2022041904151678015179&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.checkmatepharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Checkmate Pharmaceuticals, Inc.根据特拉华州法律于2015年7月成立，是一家临床阶段的生物技术公司，致力于开发和商业化其专有技术，以利用免疫系统的力量对抗癌症。","exchange":"NASDAQ","name":"Checkmate Pharmaceuticals","nameEN":"Checkmate Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Checkmate Pharmaceuticals(CMPI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Checkmate Pharmaceuticals(CMPI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Checkmate Pharmaceuticals,CMPI,Checkmate Pharmaceuticals股票,Checkmate Pharmaceuticals股票老虎,Checkmate Pharmaceuticals股票老虎国际,Checkmate Pharmaceuticals行情,Checkmate Pharmaceuticals股票行情,Checkmate Pharmaceuticals股价,Checkmate Pharmaceuticals股市,Checkmate Pharmaceuticals股票价格,Checkmate Pharmaceuticals股票交易,Checkmate Pharmaceuticals股票购买,Checkmate Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Checkmate Pharmaceuticals(CMPI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Checkmate Pharmaceuticals(CMPI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}